e.l.f. Beauty, Inc. (ELF): what the price assumes

In the published model solve dated 2026-Q2, anchored at $104.44, e.l.f. Beauty, Inc. (ELF) is priced for today's economics sustained for ~11.7 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-26.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/ELF

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 5: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.9% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: elevated (limited comparison data)

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.5%); the inversion above states its own rate.

Per-Model Detail (n=14)

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• Fiscal 2026 net sales rose 25% to $1,636.5 million across five brands, the seventh consecutive year of net sales and market share growth, with the United States at 79% of sales and international at 21%.
• The cost line grew faster than the top line: selling, general and administrative expenses rose 32% to $1,026.1 million against 25% sales growth, which is why GAAP net income for the year was $26.3 million on $1.6 billion of sales.
• Guidance for fiscal 2027 calls for net sales growth of 12% to 14%, roughly half the pace just delivered, and today's price sits at about 33 times company-wide operating profit, the top of its peer group.

Bull Case

Seven straight years of net sales and market share growth is the fact that should govern how everything else here gets read. This is a company in the land-grab phase of its life, and land-grab companies do not look good on a trailing earnings screen, because the whole point is that today's profit is being converted into tomorrow's shelf space. Fiscal 2026 net sales grew 25% to $1,636.5 million, and the fourth quarter grew 35% to $449.3 million. Nothing else in the cohort is close. COTY shrank 3.6% over the trailing year, EL grew 0.3%, KVUE was flat, CHD grew 2.2% and IPAR 1.9%. In a category where the incumbents are managing decline, e.l.f. is the only name adding meaningful volume.

The margin structure is what makes the growth worth having. Gross margin ran 71% for fiscal 2026 and reached 73% in the fourth quarter, up about 140 basis points. Sitting alongside COTY at 63.2%, CHD at 45.1% and KVUE at 58.4%, that is a mass-market price point earning a prestige gross margin. The company's own filing explains the mechanism without hedging: its value proposition rests on "Delivering premium quality products at extraordinary prices", and it spent $318.8 million on marketing and digital in the prior fiscal year, roughly 24% of net sales. The gross margin funds the marketing; the marketing buys the share; the share justifies the shelf.

The portfolio is no longer one brand. e.l.f. Cosmetics, e.l.f. SKIN, rhode, Naturium and Well People all grew in fiscal 2026, with rhode and Naturium described by management as the standouts. That matters for a reason specific to this category: a single cosmetics brand is a fashion asset with a finite life, while a house of brands with shared manufacturing, shared distribution and shared retailer relationships is an operating platform. The rhode earnout is the evidence. The company recorded a $57.6 million fair value adjustment to contingent consideration for fiscal 2026 precisely because rhode's revenue beat the thresholds written into the merger agreement. Paying more because the acquired business outperformed is the good version of that problem.

Distribution still has room, and the shape of it favours the company. Retailers accounted for 76% of fiscal 2026 net sales and e-commerce the remaining 24%, and the international business is 21% of the total. Both numbers describe headroom rather than saturation. A brand that sells through mass retail in four countries and does a quarter of its business direct is not near the ceiling of either channel, and the direct channel is where the gross margin is highest and the consumer data is proprietary.

Scale is arriving without the usual overhead. The company ran fiscal 2026 with 849 full-time employees. That is a very small organization for $1.6 billion of sales, and it is the structural reason the company can outspend larger competitors on consumer-facing marketing while still generating cash. Guidance for fiscal 2027 puts net sales at $1,835 million to $1,865 million with adjusted net income of $198 million to $201 million. Growth decelerating from 25% to the low teens is not the same as growth stopping.

Bear Case

Look at where the money went in fiscal 2026. Net sales grew 25%, to $1,636.5 million. Selling, general and administrative expense grew 32%, to $1,026.1 million. In the fourth quarter the divergence was starker still: sales rose about $117 million year over year while that same expense line rose $126.4 million. A company spending more incremental dollars than it earns incremental revenue is not scaling. It is buying growth, and the price of the growth is going up.

That shows up in the only number no adjustment can reach. GAAP net income for fiscal 2026 was $26.3 million on $1.6 billion of sales, and the fourth quarter produced a GAAP net loss of $49.4 million, a loss of $0.82 per diluted share. On the company's adjusted basis the same year produced $3.13 of diluted earnings per share against $0.44 reported. A gap of that size is not a rounding convention. It is the recurring cost of acquisitions, earnouts and stock compensation being moved outside the number management asks investors to use, in a year when those costs were the story.

Capital allocation compounded it. Total borrowings went from $256.7 million to $841.7 million over the fiscal year, and cash from $148.7 million to $289.7 million, to fund the rhode purchase. The earnout then cost another $57.6 million in fair value adjustment because rhode beat its targets. Meanwhile the share count keeps climbing: weighted average diluted shares are guided to 60.5 million in fiscal 2027 against 59 million in fiscal 2026, and the count has grown about 2.8% a year over the last four years. Debt tripled, shares kept rising, and the reported profit went sideways. Those three things happening together is what a shareholder should look at when management describes a year as strong.

The customer relationship carries no contractual floor. The 10-K states it directly: "we do not have contracts requiring retailers to make firm purchases from us. Accordingly, retailers could reduce their purchasing levels or cease buying products from us at any time and for any reason". Retailers are 76% of net sales. A cosmetics brand's shelf position at a national chain is reviewed on a schedule, and the same shelf-reset machinery that let e.l.f. take space from incumbents can hand it to whoever is trending next. Gross margin already absorbed a hit from tariffs in fiscal 2026, falling about 50 basis points from 71.2%, and the sourcing base sits in China.

All of which lands on a price that is asking for a great deal. At roughly 33 times company-wide operating profit, the multiple sits at the very top of its peer distribution, well past the upper quartile, and what it embeds is growth pinned at the fastest rate the business could fund internally, held for about seven years. Only about 30% of comparable fast-growers sustained that pace that long. The company's own fiscal 2027 guidance already calls for 12% to 14% growth, roughly half of what fiscal 2026 delivered. The deceleration is not a bear forecast. It is the company's forecast.

Valuation

The methods split cleanly here, and the split is the whole message. Only the cash-flow projections reach this price. The book-value methods land at roughly a tenth of it, the earnings-power methods around a tenth as well, and peer multiples put the price at about 2.8 times where that family lands. Those first two are not really telling you the shares are worth a tenth of what they cost; they are telling you that a company with $18.78 of book value per share and a trailing return on equity near 2.3% has almost nothing for a static method to grip. What is being bought here is not on the balance sheet.

So the honest frame is the forward one, and it is worth naming how the forward methods get there. They reach the price by carrying the recent growth rate forward: one of them projects roughly 24% annual growth off today's cash flow base for seven years. That is not an outlandish assumption given what the company has actually delivered, and it is exactly the assumption the price depends on. Invert it and the requirement becomes concrete: at about 33 times company-wide operating profit, the price embeds growth pinned at the fastest pace the business could fund from its own cash flow, sustained for roughly seven years. The rate sits inside what e.l.f. has recently delivered. The duration is the demanding part, and only about 30% of comparable fast-growers held such a pace that long.

Against the cohort, the multiple is the outlier rather than the growth. The price sits at the very top of its peer distribution, well beyond the upper quartile, on a group where COTY shrank 3.6%, EL grew 0.3%, KVUE was flat and CHD grew 2.2% over the trailing year. e.l.f. grew 25% in fiscal 2026. The market has correctly identified which company in this group is winning; the question is only what that is worth. IPAR offers the closest useful benchmark for a smaller, faster beauty operator, running an 18.0% operating margin on $1.49 billion of revenue, and it trades nowhere near this multiple.

The gap between reported and adjusted results is the piece a buyer has to form a view on, because it determines which earnings the multiple is being applied to. Fiscal 2026 produced $26.3 million of GAAP net income and $185.9 million of adjusted net income. Guidance for fiscal 2027 is framed entirely on the adjusted line, in a range of 198 to 201 million dollars, or $3.27 to $3.32 per diluted share. If the adjustments genuinely fall away as the rhode integration completes, the multiple is far less demanding than it looks. If they persist, as acquisition-driven adjustments in this category often do, the price is being set against a number the company does not report.

Solvency bounds the downside without eliminating it. Cash stood at 289.7 million dollars against 841.7 million of total borrowings at March 31, 2026. Net of the cash, that is a manageable load against a company generating this much gross profit, and it is not the kind of balance sheet that forces a decision. What it does remove is the option of another large acquisition without either more borrowing or more shares, and the share count is already rising about 2.8% a year.

Catalysts

Fiscal 2026 results landed May 20, 2026, and set the bar for the year ahead. Net sales for the twelve months to March 31, 2026 were $1,636.5 million, up 25%, with fourth-quarter net sales of $449.3 million, up 35%. The fourth quarter also carried a GAAP net loss of $49.4 million, driven by the increase in selling, general and administrative expense and by the $57.6 million fair value adjustment to the rhode contingent consideration recorded for the fiscal year.

The fiscal 2027 outlook is the number to hold management to. Net sales are guided to $1,835 million to $1,865 million, a 12% to 14% increase, with adjusted net income of $198 million to $201 million and adjusted diluted earnings per share of $3.27 to $3.32 on 60.5 million weighted average diluted shares. The adjusted effective tax rate is guided to 25% to 26% against 23% in fiscal 2026, which absorbs part of the operating improvement before it reaches the per-share line.

Two operating variables sit underneath that guidance. Tariffs already cost about 50 basis points of gross margin in fiscal 2026, and the company's contract manufacturing base is concentrated in China, so any further change in duty rates flows through cost of sales with a lag. And the retailer channel, at 76% of net sales, resets shelf space on its own schedule rather than the company's, which makes the spring and autumn reset cycles the practical checkpoints on whether the share gains of the last seven years are still compounding.

Peer Cohorts (Per Segment, With Filing Citations)

e.l.f. Beauty (consolidated) (reported)

• COTY (COTY INC.)
• FY2025 10-K: …our priorities to capitalize on structural tailwinds in the fragrance market. We are leveraging our leadership in fragrance innovation, licensing, and manufacturing to expand across price points, from mass to ultra-premium. With slower growth in China's beauty market, we have shifted focus to a broader set of…
• FY2025 10-K: …performance. See "Overview-Non-GAAP Financial Measures." A reconciliation of reported operating income (loss) to Adjusted operating income is presented below, by segment: Year Ended June 30, 2025 (in millions) Reported (GAAP) Adjustments (a) Adjusted (Non-GAAP) Adjusted operating income (loss) Prestige $ 580.6 $…
• IPAR (INTERPARFUMS, INC.)
• FY2025 10-K: …average cost of capital (i.e., the discount rate) and long-term growth rate. ● Evaluated the reasonableness of the significant assumptions used by management related to projected future sales and cash flows. ● Tested the completeness and accuracy of data used by management in their valuation model, and the…
• FY2025 10-K: …period ended December 31, 2025 F-7 Consolidated Statements of Comprehensive Income for each of the years in the three-year period ended December 31, 2025 F-8 Consolidated Statements of Changes in Shareholders' Equity for each of the years in the three-year period ended December 31, 2025 F-9 Consolidated Statements of…
• OLPX (OLAPLEX HOLDINGS, INC.)
• FY2025 10-K: …new product introductions or promotional and planning activities undertaken by us or our customers, which may impact the timing of purchases or order placement. Competition There is significant competition within each market where our products are sold. Competition in the beauty industry is based on a variety of…
• FY2025 10-K: …introductions, e-commerce initiatives, sustainability and other activities. We have seen increased competitive activity including discounting in the prestige haircare category. We believe we have a well-recognized and strong reputation within the beauty industry, from our customers to the end-consumer, and that the…
• EL (Estee Lauder Companies Inc)
• FY2025 10-K: …net sales associated with the fiscal 2024 third quarter launch in Amazon's U.S. Premium Beauty store, as well as the success of hero product franchises, including new product launches. 37 Table of Contents Makeup net sales were impacted by approximately $20 million of unfavorable foreign currency translation.…
• FY2025 10-K: …and capital resources to each reportable segment. Segment net sales and operating income is before the impacts of restructuring and other activities and the impacts from the other category described above. Returns and charges associated with restructuring and other activities are not allocated to the Company's…
• KVUE (Kenvue Inc.)
• FY2025 10-K: …realization of benefits associated with our supply chain optimization initiatives, and savings from Our Vue Forward resulting in administrative expense reductions. Skin Health and Beauty Segment Skin Health and Beauty Segment Net Sales The Skin Health and Beauty Segment Net sales were $4.1 billion and $4.2 billion…
• FY2025 10-K: …included herein for additional information. (8) Segment adjusted operating income excludes the impact of the conversion of stock-based awards that occurred on August 23, 2023 (see Note 11, "Stock-Based Compensation," to the Consolidated Financial Statements included herein for additional information). The adjustment…
• CHD (CHURCH & DWIGHT CO., INC.)
• FY2025 10-K: …based on a "relief from royalty" or "excess earnings" discounted cash flow method, which contains numerous variables that are subject to change as business conditions change, and therefore could impact fair values in the future. The key assumptions used in determining fair value are sales growth, profitability…
• FY2025 10-K: .1, or 1.6% compared to 2024 net sales. The components of the net sales increase are as follows: Net Sales - Consolidated December 31, 2025 Product volumes sold (1) 0.8 % Pricing/Product mix (2) (0.1 %) Exit of product lines (3) (1.0 %) Acquisitions (4) 1.9 % Net Sales increase 1.6 % (1) The volume change reflects…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.